NCT Number: NCT00477620
Study of Myopia Acquisition and Prevention
Purpose:
To determine whether the use of reading glasses blocks the near work mediated increased incidence of myopia in healthy school children.
Methods:
SMART enrolled 115 emmetropic children (ages 7-9 years). The children were recruited in the Principality of Liechtenstein. They were randomly assigned to either the control group (n=52) or to receive reading glasses with a lens power of +2.0 dioptres (n=63). The primary outcome measure was progression towards myopia as determined by autorefraction after cycloplegia. The secondary outcome measure was change in biometry measurements of corneal curvature, axial length, anterior chamber depth, crystalline lens thickness, and vitreous chamber depth using partial coherence interferometry.
Looking for future studies?
Notify MeKey information
Conditions
Age range
7 year–9 year
Sex eligibility
All sexes
Study type
Interventional
Phase
Not applicable
Who can participate
Healthy volunteers accepted: Yes
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
- Emmetropia
Exclusion criteria
- Ametropia
Treatment and study plan
Sponsors and collaborators
Lead sponsor
University Hospital Freiburg
Other
Registry information
Official study title
Study of Myopia Acquisition and Prevention in a Randomised Trial
Acronym: SMART
Important dates
- Study start
- 2004
- Primary completion
- 2008
- Study completion
- 2008
- First posted
- May 24, 2007
- Registry last updated
- Feb 23, 2009
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Related clinical trials
Published trials that share one or more normalized conditions with this study.
Low-Dose Atropine for Treatment of Myopia
NCT03334253
Eye Diseases, Myopia
Birmingham, Alabama, United States
View Trial DetailsPatient Reported Outcomes With WaveLight Plus LASIK
NCT07087665
Eye Diseases, Myopia
Saint Louis Park, Minnesota, United States
View Trial DetailsMeasuring Outcomes of LASIK and EVO-ICL in Matched Populations
NCT06700460
Eye Diseases, Myopia
Omaha, Nebraska, United States
View Trial DetailsCorrection of Myopia Evaluation Trial 2
NCT00320593
Eye Diseases, Myopia
Birmingham, Alabama, United States
View Trial Details